These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 201471)

  • 1. Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbits.
    Murthy VS; Waldron TL; Goldberg ME; Vollmer RR
    Eur J Pharmacol; 1977 Dec; 46(3):207-12. PubMed ID: 201471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats.
    Vollmer RR; Boccagno JA
    Eur J Pharmacol; 1977 Sep; 45(2):117-25. PubMed ID: 198216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs.
    Harris DN; Heran CL; Goldenberg HJ; High JP; Laffan RJ; Rubin B; Antonaccio MJ; Goldberg ME
    Eur J Pharmacol; 1978 Oct; 51(4):345-9. PubMed ID: 213295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
    Suzuki M; Satoh S
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.
    Rubin B; Laffan RJ; Kotler DG; O'Keefe EH; Demaio DA; Goldberg ME
    J Pharmacol Exp Ther; 1978 Feb; 204(2):271-80. PubMed ID: 202692
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.
    Campbell WG; Donohue JA; Duket LH
    Am J Pathol; 1980 Feb; 98(2):457-84. PubMed ID: 6243872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
    DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T; Becker FT; Sybertz EJ
    Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific orally active inhibitor of angiotensin-converting enzyme in man.
    Ferguson RK; Turini GA; Brunner HR; Gavras H; McKinstry DN
    Lancet; 1977 Apr; 1(8015):775-8. PubMed ID: 66571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SQ 27,786 and SQ 28,853: two angiotensin converting enzyme inhibitors with potent diuretic activity.
    DeForrest JM; Waldron TL; Powell JR; Floyd DM; Sundeen JE
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):154-9. PubMed ID: 2435992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of depressor responses to arachidonic acid by angiotensin converting enzyme inhibitors in the rat.
    Hui SC; Dai S; Ogle CW
    Clin Exp Pharmacol Physiol; 1984; 11(6):621-5. PubMed ID: 6100239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs.
    Vollmer RR; Boccagno JA; Harris DN; Murthy VS
    Eur J Pharmacol; 1978 Sep; 51(1):39-45. PubMed ID: 212276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of inhibition of angiotensin I converting enzyme with SQ-14225 on the arterial blood pressure of mongrel dogs.
    Jandhyala BS; Washington GF; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):257-65. PubMed ID: 216064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of central angiotensin I conversion by oral captopril.
    Marson O; Ribeiro AB; Tufik S; Kohlmann O; Ramos OL
    Braz J Med Biol Res; 1981 Apr; 14(1):73-6. PubMed ID: 6272920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an orally active converting-enzyme inhibitor, SQ 14225, on pressor responses to angiotensin administered into the brain ventricles of spontaneously hypertensive rats.
    Mann JF; Rascher W; Dietz R; Schömig A; Ganten D
    Clin Sci (Lond); 1979 Jan; 56(6):585-9. PubMed ID: 383371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an angiotensin converting enzyme inhibitor (SQ 14,225) on beta-adrenergic and angiotensin-induced thirsts.
    Katovich MJ; Barney CC; Fregly MJ; McCaa RE
    Eur J Pharmacol; 1979 Jun; 56(1-2):123-30. PubMed ID: 223856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.